The UnitedHealth Group leader whose murder in December unleashed a torrent of public frustration and dissatisfaction with the U.S. health care system was pushing for some of the very improvements ...

In the first public appearance since Brian Thompson's slaying in early December, UnitedHealth Group CEO Andrew Witty addressed the public's discontent, skirting responsibility and blaming drug ...

Good morning, and welcome to UnitedHealth Group fourth-quarter and full-year 2024 earnings conference call. (Operator Instructions) As a reminder, this call is being recorded. Here is some ...

10 Companies Reflect Market Decline. In this article, we are going to take a look at where UnitedHealth Group Incorporated (NYSE:UNH) stands against other companies that reflect market decline.

Growth Capital Deployment 2024: Nearly $17 billion. Shareholder Returns 2024: Over $16 billion through dividends and share repurchase. UnitedHealth Group Inc (NYSE:UNH) reported 2024 revenues of over ...

In his first public remarks since the murder of a top executive, UnitedHealth Group CEO Andrew Witty acknowledged systemic flaws in the U.S. health care system but placed the blame solely on drug ...

A major cyberattack, a beleaguered pharmacy benefits manager, rising medical expenses, and an executive killing marked a tumultuous year for UnitedHealth Group (NYSE:UNH). Then came the company's ...

In its first financial results since its insurance unit CEO was fatally shot in New York City, UnitedHealth Group reported Thursday weaker-than-expected fourth-quarter revenue, prompting its ...

UnitedHealth shares dropped nearly 5% Thursday morning after the firm disclosed worse-than-expected revenue in its first earnings report since the shocking assassination of Brian Thompson, its ...

UnitedHealth Group shares slid as the health insurer reported soft revenue from premiums and higher medical payments. Major U.S. indexes were little changed at midday Thursday after Wednesday's ...

UnitedHealth Group (UNH) shares fell 4% in intraday trading Thursday after the company reported fourth-quarter results that missed analysts' expectations. The healthcare giant's revenue grew 7% ...